With a focus on biobanking Maass outlines some common difficulties in isolating biomarkers from samples that have previously been stored in a bio/tissue bank; he shares his opinions on storage techniques for samples to get the best results. He also sheds light on the state of Roche’s internal biobank, discusses the extent to which Roche sources samples externally from biobanks, and the main difficulties/challenges with this. Finally, he gives some research-side advice for new or expanding biobanks.
Missed part one? An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 1 - DNA Sequencing
Missed part two? An Interview with Gerd Maass, VP for R&D at Roche Pharmaceuticals: Chapter 2 - Companion Diagnostics
Source (c): PharmaIQ
Keine Kommentare:
Kommentar veröffentlichen